Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2

Gabor Csanyi, Eugenia Cifuentes-Pagano, Imad Al Ghouleh, Daniel J. Ranayhossaini, Loreto Egaña, Lucia R. Lopes, Heather M. Jackson, Eric E. Kelley, Patrick J. Pagano

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

In recent years, reactive oxygen species (ROS) derived from the vascular isoforms of NADPH oxidase, Nox1, Nox2, and Nox4, have been implicated in many cardiovascular pathologies. As a result, the selective inhibition of these isoforms is an area of intense current investigation. In this study, we postulated that Nox2ds, a peptidic inhibitor that mimics a sequence in the cytosolic B-loop of Nox2, would inhibit ROS production by the Nox2-, but not the Nox1- and Nox4-oxidase systems. To test our hypothesis, the inhibitory activity of Nox2ds was assessed in cell-free assays using reconstituted systems expressing the Nox2-, canonical or hybrid Nox1-, or Nox4-oxidase. Our findings demonstrate that Nox2ds, but not its scrambled control, potently inhibited superoxide (O 2 •-) production in the Nox2 cell-free system, as assessed by the cytochrome c assay. Electron paramagnetic resonance confirmed that Nox2ds inhibits O 2 •- production by Nox2 oxidase. In contrast, Nox2ds did not inhibit ROS production by either Nox1- or Nox4-oxidase. These findings demonstrate that Nox2ds is a selective inhibitor of Nox2-oxidase and support its utility to elucidate the role of Nox2 in organ pathophysiology and its potential as a therapeutic agent.

Original languageEnglish (US)
Pages (from-to)1116-1125
Number of pages10
JournalFree Radical Biology and Medicine
Volume51
Issue number6
DOIs
StatePublished - Sep 15 2011
Externally publishedYes

Fingerprint

NADPH Oxidase
Oxidoreductases
Peptides
Reactive Oxygen Species
Assays
Protein Isoforms
Cell-Free System
Electron Spin Resonance Spectroscopy
Pathology
Cytochromes c
Superoxides
Paramagnetic resonance
Blood Vessels
peptide B

Keywords

  • Cardiovascular disease
  • Free radicals
  • NADPH oxidase
  • Nox inhibitor
  • Reactive oxygen species
  • Superoxide

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Csanyi, G., Cifuentes-Pagano, E., Al Ghouleh, I., Ranayhossaini, D. J., Egaña, L., Lopes, L. R., ... Pagano, P. J. (2011). Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radical Biology and Medicine, 51(6), 1116-1125. https://doi.org/10.1016/j.freeradbiomed.2011.04.025

Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. / Csanyi, Gabor; Cifuentes-Pagano, Eugenia; Al Ghouleh, Imad; Ranayhossaini, Daniel J.; Egaña, Loreto; Lopes, Lucia R.; Jackson, Heather M.; Kelley, Eric E.; Pagano, Patrick J.

In: Free Radical Biology and Medicine, Vol. 51, No. 6, 15.09.2011, p. 1116-1125.

Research output: Contribution to journalArticle

Csanyi, G, Cifuentes-Pagano, E, Al Ghouleh, I, Ranayhossaini, DJ, Egaña, L, Lopes, LR, Jackson, HM, Kelley, EE & Pagano, PJ 2011, 'Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2', Free Radical Biology and Medicine, vol. 51, no. 6, pp. 1116-1125. https://doi.org/10.1016/j.freeradbiomed.2011.04.025
Csanyi G, Cifuentes-Pagano E, Al Ghouleh I, Ranayhossaini DJ, Egaña L, Lopes LR et al. Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radical Biology and Medicine. 2011 Sep 15;51(6):1116-1125. https://doi.org/10.1016/j.freeradbiomed.2011.04.025
Csanyi, Gabor ; Cifuentes-Pagano, Eugenia ; Al Ghouleh, Imad ; Ranayhossaini, Daniel J. ; Egaña, Loreto ; Lopes, Lucia R. ; Jackson, Heather M. ; Kelley, Eric E. ; Pagano, Patrick J. / Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. In: Free Radical Biology and Medicine. 2011 ; Vol. 51, No. 6. pp. 1116-1125.
@article{a9ee4ddad6114f1bac5e9f3ee64cedcc,
title = "Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2",
abstract = "In recent years, reactive oxygen species (ROS) derived from the vascular isoforms of NADPH oxidase, Nox1, Nox2, and Nox4, have been implicated in many cardiovascular pathologies. As a result, the selective inhibition of these isoforms is an area of intense current investigation. In this study, we postulated that Nox2ds, a peptidic inhibitor that mimics a sequence in the cytosolic B-loop of Nox2, would inhibit ROS production by the Nox2-, but not the Nox1- and Nox4-oxidase systems. To test our hypothesis, the inhibitory activity of Nox2ds was assessed in cell-free assays using reconstituted systems expressing the Nox2-, canonical or hybrid Nox1-, or Nox4-oxidase. Our findings demonstrate that Nox2ds, but not its scrambled control, potently inhibited superoxide (O 2 •-) production in the Nox2 cell-free system, as assessed by the cytochrome c assay. Electron paramagnetic resonance confirmed that Nox2ds inhibits O 2 •- production by Nox2 oxidase. In contrast, Nox2ds did not inhibit ROS production by either Nox1- or Nox4-oxidase. These findings demonstrate that Nox2ds is a selective inhibitor of Nox2-oxidase and support its utility to elucidate the role of Nox2 in organ pathophysiology and its potential as a therapeutic agent.",
keywords = "Cardiovascular disease, Free radicals, NADPH oxidase, Nox inhibitor, Reactive oxygen species, Superoxide",
author = "Gabor Csanyi and Eugenia Cifuentes-Pagano and {Al Ghouleh}, Imad and Ranayhossaini, {Daniel J.} and Loreto Ega{\~n}a and Lopes, {Lucia R.} and Jackson, {Heather M.} and Kelley, {Eric E.} and Pagano, {Patrick J.}",
year = "2011",
month = "9",
day = "15",
doi = "10.1016/j.freeradbiomed.2011.04.025",
language = "English (US)",
volume = "51",
pages = "1116--1125",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2

AU - Csanyi, Gabor

AU - Cifuentes-Pagano, Eugenia

AU - Al Ghouleh, Imad

AU - Ranayhossaini, Daniel J.

AU - Egaña, Loreto

AU - Lopes, Lucia R.

AU - Jackson, Heather M.

AU - Kelley, Eric E.

AU - Pagano, Patrick J.

PY - 2011/9/15

Y1 - 2011/9/15

N2 - In recent years, reactive oxygen species (ROS) derived from the vascular isoforms of NADPH oxidase, Nox1, Nox2, and Nox4, have been implicated in many cardiovascular pathologies. As a result, the selective inhibition of these isoforms is an area of intense current investigation. In this study, we postulated that Nox2ds, a peptidic inhibitor that mimics a sequence in the cytosolic B-loop of Nox2, would inhibit ROS production by the Nox2-, but not the Nox1- and Nox4-oxidase systems. To test our hypothesis, the inhibitory activity of Nox2ds was assessed in cell-free assays using reconstituted systems expressing the Nox2-, canonical or hybrid Nox1-, or Nox4-oxidase. Our findings demonstrate that Nox2ds, but not its scrambled control, potently inhibited superoxide (O 2 •-) production in the Nox2 cell-free system, as assessed by the cytochrome c assay. Electron paramagnetic resonance confirmed that Nox2ds inhibits O 2 •- production by Nox2 oxidase. In contrast, Nox2ds did not inhibit ROS production by either Nox1- or Nox4-oxidase. These findings demonstrate that Nox2ds is a selective inhibitor of Nox2-oxidase and support its utility to elucidate the role of Nox2 in organ pathophysiology and its potential as a therapeutic agent.

AB - In recent years, reactive oxygen species (ROS) derived from the vascular isoforms of NADPH oxidase, Nox1, Nox2, and Nox4, have been implicated in many cardiovascular pathologies. As a result, the selective inhibition of these isoforms is an area of intense current investigation. In this study, we postulated that Nox2ds, a peptidic inhibitor that mimics a sequence in the cytosolic B-loop of Nox2, would inhibit ROS production by the Nox2-, but not the Nox1- and Nox4-oxidase systems. To test our hypothesis, the inhibitory activity of Nox2ds was assessed in cell-free assays using reconstituted systems expressing the Nox2-, canonical or hybrid Nox1-, or Nox4-oxidase. Our findings demonstrate that Nox2ds, but not its scrambled control, potently inhibited superoxide (O 2 •-) production in the Nox2 cell-free system, as assessed by the cytochrome c assay. Electron paramagnetic resonance confirmed that Nox2ds inhibits O 2 •- production by Nox2 oxidase. In contrast, Nox2ds did not inhibit ROS production by either Nox1- or Nox4-oxidase. These findings demonstrate that Nox2ds is a selective inhibitor of Nox2-oxidase and support its utility to elucidate the role of Nox2 in organ pathophysiology and its potential as a therapeutic agent.

KW - Cardiovascular disease

KW - Free radicals

KW - NADPH oxidase

KW - Nox inhibitor

KW - Reactive oxygen species

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=80051802409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051802409&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2011.04.025

DO - 10.1016/j.freeradbiomed.2011.04.025

M3 - Article

VL - 51

SP - 1116

EP - 1125

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 6

ER -